WO1990014773A1 - Nutritional composition containing an enzyme - Google Patents

Nutritional composition containing an enzyme Download PDF

Info

Publication number
WO1990014773A1
WO1990014773A1 PCT/FR1990/000374 FR9000374W WO9014773A1 WO 1990014773 A1 WO1990014773 A1 WO 1990014773A1 FR 9000374 W FR9000374 W FR 9000374W WO 9014773 A1 WO9014773 A1 WO 9014773A1
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
composition according
constituent
composition
food
Prior art date
Application number
PCT/FR1990/000374
Other languages
French (fr)
Inventor
Jean-Luc Barry
Original Assignee
Institut National De La Recherche Agronomique (Inra)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Recherche Agronomique (Inra) filed Critical Institut National De La Recherche Agronomique (Inra)
Publication of WO1990014773A1 publication Critical patent/WO1990014773A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022Alpha-galactosidase (3.2.1.22)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/189Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/104Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A23L7/107Addition or treatment with enzymes not combined with fermentation with microorganisms

Definitions

  • the present invention relates to the field of human or animal nutrition. It particularly relates to an original food composition and a process for enhancing the value of certain products already used in food.
  • Proteins, fats and most carbohydrates are quickly hydrolyzed into small molecules which are then absorbed and used by the body.
  • certain substrates mainly of a carbohydrate nature, escape digestion due to a deficiency of enzymes necessary for their hydrolysis.
  • alpha-galactosides parietal carbohydrates which are the major constituents of fibers, such as cellulose or hemi-celluloses, pectins, lignin.
  • Other substances are also interested in this type of problem, even if these are found in lesser quantities or anecdotally, these include phytates, polyphenols, tannins, cutins, or even inulin found for example in large quantities in Jerusalem artichoke or in artichokes.
  • Other substances forming part of the food bolus but having been introduced for a non-nutritional purpose, for example for the purpose of preserving or coloring the food, are also affected by this problem. Chemically these additives can be classified among gums, mucilages, ⁇ lginates and car raghénates.
  • Alpha-galactosides are defined as oligosaccharides of the general formula: (galactose) n- sucrose. These small, polymers due to a deficiency of higher organisms in alpha-galactosidase, are not hydrolyzed in the small intestine. They therefore arrive intact in the colon where they are fermented under the action of numerous microorganisms with gas production. This results in two major drawbacks, on the one hand an overall reduction in the energy value of the food, and on the other hand this fermentation is a source of discomfort for humans or animals, and it can cause digestive disorders. A depolymerization of alpha-galactosides to galactose and sucrose easily metabolizable by the body would solve these problems. However, the destruction of these alpha-galactosides requires the use of enzymes. Indeed, these compounds are very resistant and cannot be altered by the usual chemical and physical processes.
  • the subject of this application is also a method of degrading the oligosaccharides and monosaccharides contained in soy milk, said method being characterized in that fermentation extracts of the strain claimed are brought into contact with soy.
  • This prior document describes a reduction in soy milk of the rate of stachyosis, passing from 5.5% to 0.1%, and of raffinose, passing from 1.5% to 1%, after treatment.
  • the present invention relates to a composition
  • a composition comprising at least one product for human or animal consumption and at least one enzyme, said enzyme allowing the in situ degradation of undigested substances under normal physiological conditions, as well as a process for the enhancement of 'A product for human or animal food, said product containing at least one component escaping digestion under normal physiological conditions.
  • the object of the invention is therefore a composition containing a product for human or animal food and an enzyme whose activity allows degradation in situ, that is to say in the digestive tract of man or of the animal substances which escape non-microbial digestion under normal physiological conditions.
  • This enzyme at least partially resists degradation by proteases of the digestive system and has a significant activity of degradation of the substances of which it is specific. Said enzyme functions optimally under physiological conditions of the digestive tract and moreover does not present toxicity either for the man or for the animal.
  • the object of the invention is therefore a composition
  • a composition comprising at least one product for human or animal food, said product containing at least one constituent escaping degradation during non-microbial digestion by the body, said composition being characterized in that it further comprises at least one enzyme capable of hydrolyzing said constituent during digestion tion, said enzyme not being naturally present in the digestive system and being substantially without effect on said constituent before ingestion of the composition.
  • the expression "enzyme not naturally present in the digestive tract” means that this enzyme is not synthesized, or is synthesized in insignificant quantity, by the organism under normal conditions of digestion. This expression therefore excludes enzymes originating from host microorganisms in the digestive tract.
  • the composition is presented in a dry form and in particular in the form of flour or in agglomerated form, such as granules, or other forms of presentation usual in human or animal food. .
  • This type of presentation is of notable interest for animal nutrition.
  • Products suitable for food can be in particular grains, seeds, oil cakes and other industrial by-products.
  • the enzyme is specific to the constituent (s) to be hydrolyzed in said product for human or animal food, and said enzyme is present in an amount effective for at least partially hydrolyzing said consti killing during digestion.
  • this enzyme is chosen from specific enzymes whose activity is optimal under the conditions, in particular of pH and temperature, of digestion in the organism. This enzyme can be in a purified form, or can be mixed with other enzymes having other activities.
  • the enzyme can also be added in the form of a preparation of microorganisms capable of producing said enzyme.
  • an enzyme of any origin or mixtures of such enzymes, the only condition being that the enzymatic preparation has the desired enzymatic activity. It is thus possible to use enzymes originating from bacteria, yeasts or fungi or even synthetic enzymes.
  • said enzyme is heat-resistant, in particular with a view to withstanding the temperatures involved in the preparation of the composition.
  • composition is prepared by methods known in themselves by those skilled in the art, by intimate mixing of the specific enzyme and of the product for human or animal consumption, optionally followed by agglomeration treatment.
  • the subject of the invention is also a process for the enhancement of a product for human or animal consumption, containing at least one constituent which escapes digestion in the body, said process being characterized in that one mixes intimately to said product an effective amount of at least one enzyme capable of hydrolyzing said constituent during digestion, said enzyme not being present naturally in the digestive tract and being substantially without effect on said constituent before ingestion of the composition.
  • the description which follows gives by way of illustration and without limitation an example of application of the invention to alpha-galactosides,
  • the BE diet was obtained by adding 5% of the enzyme to the B diet.
  • the BR diet was carried out from the B diet by adding 5% raffinose.
  • the BRE diet was formed by adding 5% raffinose and 5% enzyme to diet B.
  • Cellulose is a wood type cellulose
  • COLMALCEL The composition of the mineral supplement (CM) is given in table 2 and that of the vitamin supplement (CV) is given in table 3.
  • the raffinose was supplied by the SIGMA company (R0250) and the enzymatic preparation is a cellulase preparation of the Dutch company GI5T-BROCADES, containing a secondary alpha-galactosidasic activity.
  • the galactosidasic activity was determined by the method of BERGMEYER (1974 - Methods of enzymatic analysis - Académie Press, New York). The activity is assayed by release of phenol after action of the enzyme on para-nitro-phenyl-gaiactose (PNPGal). 0.4 ml of a 4 mM solution of PNPGal in 0.1 mM phosphate buffer at pH 6.5 and 0.4 ml of a 0.01 M enzyme solution in 0.1 phosphate buffer mM at pH 6.5 are incubated at 40 ° C for 0, 10, 20 and 30 minutes. Then 0.1 ml of the reaction medium is added to 0.6 ml of a 1M sodium carbonate solution. The optical density is read at 400 nm. The slope of the line obtained as a function of the duration of the incubation makes it possible to estimate the alpha-galactosidasic activity.
  • the enzyme used has an activity corresponding to the degradation of 52 mg of raffinose per mg of enzyme in 2 hours at 40 ° C and pH 6.5.
  • the raffinose contents were determined on BR and BRE foods. In order to take into account the changes likely to occur at 25 ° C during the measurement period, the food was kept for 3 days at this temperature before analysis.
  • the raffinose was extracted with an ethanol / water mixture (80/20) at boiling point and at reflux; the use of ethanol makes it possible to rapidly inactivate any alpha-galactosidasic activity.
  • the raffinose was determined by chroma togreph ie high pressure liquid according to the QUEMENER method (1988 - Improvement in the high pressure liquid chromatographic determination of amino-sugars and alpha-gaiactosides in Faba bean, lupine and pea. J. Agric. Food. Chem -36: 754 - 759).
  • the raffinose content was measured in BR and BRE foods in order to determine the rate of hydrolysis under the possible action of alpha-galactosidase.
  • the raffinose content of the two foods is identical and equal to 5.15% of dry matter (DM): the enzyme does not hydrolyze raffinose in the food and the animals received identical amounts of raffinose.
  • the experiment was carried out on 4 male rats of the WISTAR breed receiving successively, in a random order, according to a Latin square device (Table 4), four regimes (PI, PII, PIII, PIV) differing in their alpha- galactosides and alpha-galactosidase.
  • the animals were 8 weeks old at the start of the experiment and 15 weeks old at the end of the experiment.
  • the experiment therefore includes 4 periods corresponding to each of the 4 diets.
  • Each period includes an adaptation period of 9 days, carried out in individual growth cages and a measurement period of 3 days.
  • the animals were fed ad libitum; food was distributed daily. Refusals were collected daily and grouped over the duration of the period. The DM contents of the food and the rejects were determined by drying at constant weight at 100 ° C.
  • the food was distributed at once at the rate of 110% of the 3-day consumption measured during the adaptation period. Refusals were collected at the end of the measurement period. The DM content of the food and the refusals have been determined.
  • Figure 1 is a graph illustrating the influence of the nature of the diets on animal growth. The figures corresponding to the growth of the rats were plotted on the ordinate, expressed in grams calculated over three days.
  • the consumption index averages 4.4. This high value essentially reflects a low growth of the animals; the conditions of restraint imposed by the presence in the respiratory chamber may explain this result.
  • the measurement of intestinal gas production following the experimental regimes was carried out by means of a respiratory chamber, the diagram of which is shown in Figure 1.
  • the experimental animal is placed in an enclosure (1) where it has at its water at will and the food tested. Air renewal and homogenization are ensured by a diaphragm pump (2). Carbon dioxide (CO 2 ) released is captured by bar kicking in an aqueous solution of potash (3). The water from respiration is fixed by passage over ACTIGEL silica gel (4).
  • An oxygen electrode (5) placed at the outlet of the cage, measures the concentration of the oxygen circuit and makes it possible to keep it constant by action on a regulator (6) connected to a solenoid valve (7), itself connected to a cylinder of oxygen (8).
  • the direction of gas flow in the device is indicated by the arrow (F).
  • the temperature was maintained at 25 ° C; the humidity, continuously monitored, was between 50 and 60%.
  • the hydrogen concentrations for the different regimes are shown in Table 6.
  • the BR regime gives very high values and significantly different from the other regimes (p ⁇ 0.05).
  • the presence of alpha-galactosidase leads to an almost total disappearance of the fermentations, lowered to the level of the basic regime.
  • the B and BE diets give very similar results: the enzyme preparation added to the diet has no effect on the parietal fraction of the food. Its only detectable action therefore consists in a degradation of the raffinose contained in the experimental regimes.
  • the major result of this experiment is the demonstration of a reduction in the fermentations linked to the ingestion of raffinose following the incorporation of an alpha-galactosidasic activity in the food.
  • the absence of fermentation translates to a total hydrolysis of raffinose which no longer reaches the colon.
  • Raffinose is not hydrolyzed in the food where it was found intact: the action of the enzyme is located in the digestive tract.
  • the level of incorporation of the enzyme and its conditions of action close to those existing in the small intestine, led to a total hydrolysis of the added raffinose.
  • the conditions of action of the enzyme, close to those existing in the small intestine and the level of incorporation of the enzyme into the diet are favorable parameters.
  • This experiment demonstrates the activity in the digestive tract of an enzyme incorporated into the food.
  • the experience also shows that the alpha-galac tos idase studied resists degradation by endogenous enzymes and expresses its potential in the digestive tract, thus allowing, added to a diet to completely destroy the alpha-galactosides.

Abstract

A composition containing a food product for human or animal consumption, said product containing a constituant which does not decompose when digested by the organism, and an enzyme capable of hydrolyzing said constituant. The invention further relates to a method for valorizing such a product for human or animal consumption.

Description

Composition alimentaire contenant un enzyme  Food composition containing an enzyme
La présente invention concerne le domaine de l'alimentation humaine ou animale. Elle a particulièrement pour objet une composition alimentaire originale ainsi qu'un procédé pour valoriser de manière améliorée certains produits déjà utilisés en alimentation.  The present invention relates to the field of human or animal nutrition. It particularly relates to an original food composition and a process for enhancing the value of certain products already used in food.
Il est bien connu que certaines substances résistent à la digestion. Les organismes supérieurs possèdent au niveau de leur tube digestif des complexes enzymatiques permettant de dégrader l'essentiel des composés organiques des aliments. Par organismes supérieurs on entend, au sens de la présente description, l'homme ou les animaux de rente, de compagnie ou de laboratoire.  It is well known that certain substances are resistant to digestion. Higher organisms have enzymatic complexes in their digestive tract that make it possible to degrade most of the organic compounds in food. By higher organisms is understood, within the meaning of this description, the man or the animals of production, company or laboratory.
Les protides, les lipides et la plupart des glucides sont hydrolyses rapidement en petites molécules ensuite absorbées et utilisées par l'organisme. Cependant certains substrats, principalement de nature glucidique, échappent à la digestion par suite d'une carence en enzymes nécessaires à leur hydrolyse.  Proteins, fats and most carbohydrates are quickly hydrolyzed into small molecules which are then absorbed and used by the body. However, certain substrates, mainly of a carbohydrate nature, escape digestion due to a deficiency of enzymes necessary for their hydrolysis.
Ce sont principalement les alpha-galactosides, les glucides pariétaux qui sont les constituants majeurs des fibres, telles que la cellulose ou les hémi-celluloses, les pectines, la lignine. D'autres substances sont aussi intéressées par ce type de problème, même si ces dernières sont trouvées en quantité moindre ou de manière anecdotique, il s'agit notamment de phytates, de polyphénols, de tannins, de cutines, ou même d'inuline trouvée par exemple en grande quantité dans le topinambour ou dans l'artichaut. D'autres substances faisant parties du bol alimentaire mais ayant été introduites dans un but non nutritionnel, par exemple dans un but de conservation ou de coloration de l'aliment, sont aussi concernées par ce problème. Chimiquement ces additifs peuvent être classés parmi les gommes, les mucilages, les βlginates et les car raghénates.  It is mainly alpha-galactosides, parietal carbohydrates which are the major constituents of fibers, such as cellulose or hemi-celluloses, pectins, lignin. Other substances are also interested in this type of problem, even if these are found in lesser quantities or anecdotally, these include phytates, polyphenols, tannins, cutins, or even inulin found for example in large quantities in Jerusalem artichoke or in artichokes. Other substances forming part of the food bolus but having been introduced for a non-nutritional purpose, for example for the purpose of preserving or coloring the food, are also affected by this problem. Chemically these additives can be classified among gums, mucilages, βlginates and car raghénates.
Les alpha-galactosides sont définis comme des oligosaccharides de formule générale: (galactose)n-saccharose. Ces petits, polymères par suite d'une déficience des organismes supérieurs en alpha-galactosidase, ne sont pas hydrolyses dans l' intestin grêle. Ils parviennent donc intacts dans le colon où ils sont fermentes sous l'action de nombreux mi - croorgan ismes avec production de gaz. Il en résulte deux inconvénients majeurs, d'une part une diminution globale de la valeur énergétique de l'aliment, et d'autre part cette fermentation est une source d'inconfort pour l'homme ou l'animal, et elle peut provoquer des troubles digestifs. Une dépolymérisation des alpha-galactosides en galactose et saccharose facilement métabolisables par l'organisme permettrait de résoudre ces problèmes. Cependant la destruction de ces alpha-galactosides nécessite l'emploi d'enzymes. En effet, ces composés sont très résistants et ne peuvent être altérés par les procédés chimiques et physiques habituels. Alpha-galactosides are defined as oligosaccharides of the general formula: (galactose) n- sucrose. These small, polymers due to a deficiency of higher organisms in alpha-galactosidase, are not hydrolyzed in the small intestine. They therefore arrive intact in the colon where they are fermented under the action of numerous microorganisms with gas production. This results in two major drawbacks, on the one hand an overall reduction in the energy value of the food, and on the other hand this fermentation is a source of discomfort for humans or animals, and it can cause digestive disorders. A depolymerization of alpha-galactosides to galactose and sucrose easily metabolizable by the body would solve these problems. However, the destruction of these alpha-galactosides requires the use of enzymes. Indeed, these compounds are very resistant and cannot be altered by the usual chemical and physical processes.
Dans l'état des connaissances du Demandeur, le traitement des aliments pour animaux en vue de la dégradation des substances ne pouvant être digérées dans des conditions physiologiques normales dans le tube digestif, a toujours eu lieu avant l'ingestion par l'animal de sa nourriture. A titre illustratif, un procédé pour la dégradationd'alpha-galactosides a fait l'objet d'une demande de brevet européen N° 0.081.262. Celle-ci concerne une souche de Saccharomyces cerevisiae capable de produire une activité alpha-galactosidasique ainsi qu'une méthode de préparation de ce microorganisme. Cette demande a aussi pour objet une méthode de dégradation des oligo-saccharides et mono- saccharides contenus dans le lait de soja, ladite méthode étant caractérisée en ce que l'on met en contact des extraits de fermentation de la souche revendiquée avec le lait de soja. Ce document antérieur décrit une diminution dans le lait de soja du taux de stachyose, passant de 5,5% à 0,1%, et de raffinose, passant de 1,5% à 1%, après traitement.  In the Applicant's state of knowledge, the processing of animal feed with a view to the degradation of substances which cannot be digested under normal physiological conditions in the digestive tract has always taken place before the animal's ingestion of its food. By way of illustration, a process for the degradation of alpha-galactosides has been the subject of a European patent application No. 0.081.262. This relates to a strain of Saccharomyces cerevisiae capable of producing an alpha-galactosidasic activity as well as a method of preparation of this microorganism. The subject of this application is also a method of degrading the oligosaccharides and monosaccharides contained in soy milk, said method being characterized in that fermentation extracts of the strain claimed are brought into contact with soy. This prior document describes a reduction in soy milk of the rate of stachyosis, passing from 5.5% to 0.1%, and of raffinose, passing from 1.5% to 1%, after treatment.
Tous les procédés de dégradation par traitement enzymatique de substances non dégradables, connus à ce jour, sont des traitements effectués avant l' ingestion de l'aliment par l'homme ou l'animal. Le fait de de voir insérer une telle étape de dégradation avant l' ingestion représente un inconvénient majeur pour l' industrie agro-alimentaire, car notamment elle nécessite des quantités d'eau importantes; de plus les monomères ainsi libérés peuvent alors être dégradés avant l' ingestion par l'animal. All the degradation processes by enzymatic treatment of non-degradable substances, known to date, are treatments carried out before ingestion of the food by humans or animals. The fact of having such a degradation step inserted before ingestion represents a major drawback for the food industry, since in particular it requires large quantities of water; moreover, the monomers thus released can then be degraded before ingestion by the animal.
La présente invention concerne une composition comprenant au moins un produit pour l'alimentation humaine ou animale et au moins un enzyme, ledit enzyme permettant la dégradation in situ de substances non digérées dans les conditions physiologiques normales, ainsi qu'un procédé pour la valorisation d'un produit pour l'alimentation humaine ou animale, ledit produit contenant au moins un constituant échappant à la digestion dans les conditions physiologiques normales.  The present invention relates to a composition comprising at least one product for human or animal consumption and at least one enzyme, said enzyme allowing the in situ degradation of undigested substances under normal physiological conditions, as well as a process for the enhancement of 'A product for human or animal food, said product containing at least one component escaping digestion under normal physiological conditions.
L'objet de l' invention est donc une composition contenant un produit pour l'alimentation humaine ou animale et un enzyme dont l'activité permet la dégradation in situ, c'est-à-dire dans le tube digestif de l'homme ou de l'animal des substances échappant à la digestion non-microbienne dans les conditions physiologiques normales. Cet enzyme résiste au moins partiellement à la dégradation par les protéases du système digestif et possède une activité importante de dé- gradation des substances dont il est spécifique. Ledit enzyme fonctionne de manière optimale dans les conditions physiologiques du tube digestif et de plus ne présente de toxicité ni pour l'homme ni pour l'animal.  The object of the invention is therefore a composition containing a product for human or animal food and an enzyme whose activity allows degradation in situ, that is to say in the digestive tract of man or of the animal substances which escape non-microbial digestion under normal physiological conditions. This enzyme at least partially resists degradation by proteases of the digestive system and has a significant activity of degradation of the substances of which it is specific. Said enzyme functions optimally under physiological conditions of the digestive tract and moreover does not present toxicity either for the man or for the animal.
L'objet de l'invention est donc une composition comprenant au moins un produit pour l'alimentation humaine ou animale, ledit produit contenant au moins un constituant échappant à la dégradation lors de la digestion non microbienne par l'organisme, ladite composition étant caractérisée en ce qu'elle comprend en outre au moins un enzyme capable d'hydrolyser ledit constituant au cours de la diges tion, ledit enzyme n'étant pas présent naturellement dans le système digestif et étant sensiblement sans effet sur ledit constituant avant l'ingestion de la composition. The object of the invention is therefore a composition comprising at least one product for human or animal food, said product containing at least one constituent escaping degradation during non-microbial digestion by the body, said composition being characterized in that it further comprises at least one enzyme capable of hydrolyzing said constituent during digestion tion, said enzyme not being naturally present in the digestive system and being substantially without effect on said constituent before ingestion of the composition.
Au sens de la présente description, l'expression "enzyme non présent naturellement dans le tube digestif" signifie que cet enzyme n'est pas synthétisé, ou est synthétisé en quantité insignifiante, par l'organisme dans les conditions normales de la digestion. Cette expression exclut donc les enzymes provenant de microorganismes hôtes du tube digestif.  Within the meaning of the present description, the expression "enzyme not naturally present in the digestive tract" means that this enzyme is not synthesized, or is synthesized in insignificant quantity, by the organism under normal conditions of digestion. This expression therefore excludes enzymes originating from host microorganisms in the digestive tract.
Il n'était nullement prévisible que l'enzyme se trouvant sous forme sèche, au sein de la composition alimentaire, puisse exercer son activité de manière efficace lors de la digestion. On sait à ce sujet que, dans de nombreux cas, les enzymes sont dégradés dans la partie antérieure du système digestif à un point tel qu' ils perdent leur activité spécifique. Une autre difficulté est que l'enzyme, même après avoir résisté aux premières phases de la digestion, puisse exercer son activité dans les conditions de pH et de température propres à celle-ci.  It was by no means foreseeable that the enzyme found in dry form, within the food composition, could exert its activity effectively during digestion. It is known in this connection that, in many cases, the enzymes are degraded in the anterior part of the digestive system to such an extent that they lose their specific activity. Another difficulty is that the enzyme, even after having resisted the first stages of digestion, can exercise its activity under the pH and temperature conditions specific to it.
Dans un mode de mise en oeuvre préféré de l'invention, la composition est présentée sous une forme sèche et notamment sous forme de farine ou sous forme agglomérée, tels que des granulés, ou autres formes de présentation usuelle dans l'alimentation humaine ou animale. Ce type de présentation présente un intérêt notable pour la nutrition des an imaux.  In a preferred embodiment of the invention, the composition is presented in a dry form and in particular in the form of flour or in agglomerated form, such as granules, or other forms of presentation usual in human or animal food. . This type of presentation is of notable interest for animal nutrition.
Les produits convenant à l'alimentation peuvent être notamment les grains, graines, tourteaux et autres sous produits industriels.  Products suitable for food can be in particular grains, seeds, oil cakes and other industrial by-products.
Selon un autre mode de mise en oeuvre de l'invention, l'enzyme est spécifique du ou des constituants à hydrolyser dans ledit produit pour l'alimentation humaine ou animale, et ledit enzyme est présent en une quantité efficace pour hydrolyser au moins partiellement ledit consti tuant au cours de la digestion. Selon un autre mode de mise en oeuvre de l'invention, cet enzyme est choisi parmi les enzymes spécifiques dont l'activité est optimale dans les conditions, notamment de pH et de température, de la digestion dans l'organisme. Cet enzyme peut être sous une forme purifiée, ou être mélangé à d'autres enzymes ayant d'autres activités. According to another embodiment of the invention, the enzyme is specific to the constituent (s) to be hydrolyzed in said product for human or animal food, and said enzyme is present in an amount effective for at least partially hydrolyzing said consti killing during digestion. According to another embodiment of the invention, this enzyme is chosen from specific enzymes whose activity is optimal under the conditions, in particular of pH and temperature, of digestion in the organism. This enzyme can be in a purified form, or can be mixed with other enzymes having other activities.
On peut aussi ajouter l'enzyme sous forme d'une préparation de microorganismes capables de produire ledit enzyme.  The enzyme can also be added in the form of a preparation of microorganisms capable of producing said enzyme.
Pour les besoins de l'invention, on peut utiliser un enzyme d'origine quelconque, ou des mélanges de tels enzymes, la seule condition étant que la préparation enzymatique possède l'activité enzymatique recherchée. On peut ainsi mettre en oeuvre des enzymes provenant de bactéries, de levures ou de champignons ou même des enzymes synthétiques.  For the purposes of the invention, it is possible to use an enzyme of any origin, or mixtures of such enzymes, the only condition being that the enzymatic preparation has the desired enzymatic activity. It is thus possible to use enzymes originating from bacteria, yeasts or fungi or even synthetic enzymes.
Selon un autre mode de mise en oeuvre de l'invention, ledit enzyme est thermorésistant, notamment en vue de résister aux températures mises en jeu dans la préparation de la composition.  According to another embodiment of the invention, said enzyme is heat-resistant, in particular with a view to withstanding the temperatures involved in the preparation of the composition.
Ladite composition est préparée par des procédés connus en eux mêmes par l'homme de l'art, par mélange intime de l'enzyme spécifique et du produit pour l'alimentation humaine ou animale, suivi éventuellement d'un traitement d'agglomération.  Said composition is prepared by methods known in themselves by those skilled in the art, by intimate mixing of the specific enzyme and of the product for human or animal consumption, optionally followed by agglomeration treatment.
L'invention a également pour objet, un procédé pour la valorisation d'un produit pour l'alimentation humaine ou animale, contenant au moins un constituant échappant à la digestion dans l'organisme, ledit procédé étant caractérisé en ce que l'on mélange intimement audit produit une quantité efficace d'au moins un enzyme capable d'hydrolyser ledit constituant au cours de la digestion, ledit enzyme n'étant pas présent naturellement dans le tube digestif et étant sensiblement sans effet sur ledit constituant avant l'ingestion de la composition. La description qui suit donne à titre illustratif et non limitatif un exemple d'application de l' invention aux alpha-galactosides, The subject of the invention is also a process for the enhancement of a product for human or animal consumption, containing at least one constituent which escapes digestion in the body, said process being characterized in that one mixes intimately to said product an effective amount of at least one enzyme capable of hydrolyzing said constituent during digestion, said enzyme not being present naturally in the digestive tract and being substantially without effect on said constituent before ingestion of the composition. The description which follows gives by way of illustration and without limitation an example of application of the invention to alpha-galactosides,
EXEMPLE EXAMPLE
Comparaison de l'efficacité de quatre régimes alimentaires chez le rat Comparison of the efficacy of four diets in rats
a ) Composition des régimes alimentaires a) Composition of diets
L es quatre régimes suivants ont été utilisés:  The following four regimes were used:
- le régime de base (B) dont la composition figure tableau 1 a été conçu de manière à contenir un minimum de substances fermentescibles et à couvrir les besoins de rats en croissance. Ce régime a servi de base à la constitution des autres régimes expérimentaux.  - the basic diet (B), the composition of which appears in Table 1, was designed so as to contain a minimum of fermentable substances and to cover the needs of growing rats. This regime served as the basis for the constitution of the other experimental regimes.
- le régime BE a été obtenu par adjonction de 5% de l'enzyme au régime B.  - the BE diet was obtained by adding 5% of the enzyme to the B diet.
le régime BR a été réalisé à partir du régime B par adjonction de 5% de raffinose.  the BR diet was carried out from the B diet by adding 5% raffinose.
- le régime BRE a été constitué par adjonction de 5% de raffinose et 5% d'enzyme au régime B.  - the BRE diet was formed by adding 5% raffinose and 5% enzyme to diet B.
La cellulose est une cellulose de bois de type Cellulose is a wood type cellulose
COLMALCEL. La composition du complément minéral (CM) est donnée dans le tableau 2 et celle du complément vitaminique (CV) est donnée dans le tableau 3. COLMALCEL. The composition of the mineral supplement (CM) is given in table 2 and that of the vitamin supplement (CV) is given in table 3.
Dans le cas des régimes BR et BRE, le raffinose a été fourni par la Société SIGMA (R0250) et la préparation enzymatique est une préparation cellulasique de la Société hollandaise GI5T-BROCADES, contenant une activité secondaire alpha-galactosidasique.  In the case of the BR and BRE regimes, the raffinose was supplied by the SIGMA company (R0250) and the enzymatic preparation is a cellulase preparation of the Dutch company GI5T-BROCADES, containing a secondary alpha-galactosidasic activity.
L'activité galactosidasique a été déterminée par la méthode de BERGMEYER (1974 - Methods of enzymatic analysis - Académie Press, New York). L'activité est dosée par libération de phénol après action de l'enzyme sur du para-nitro-phényl-gaiactose (PNPGal). 0,4 ml d'une solution 4 mM de PNPGal en tampon phosphate 0,1 mM Mà pH 6,5 et 0,4 ml d'une solution enzymatique à 0,01 M en tampon phosphate 0,1 mM à pH 6,5 sont mises à incuber à 40°C pendant 0, 10, 20 et 30 minutes. Ensuite 0,1 ml du milieu réactionnel est ajouté à 0,6 ml d'une solution de carbonate de sodium 1M. La densité optique est lue à 400 nm. La pente de la droite obtenue en fonction de la durée de l'incubation permet d'estimer l'activité alpha-galactosidasique. The galactosidasic activity was determined by the method of BERGMEYER (1974 - Methods of enzymatic analysis - Académie Press, New York). The activity is assayed by release of phenol after action of the enzyme on para-nitro-phenyl-gaiactose (PNPGal). 0.4 ml of a 4 mM solution of PNPGal in 0.1 mM phosphate buffer at pH 6.5 and 0.4 ml of a 0.01 M enzyme solution in 0.1 phosphate buffer mM at pH 6.5 are incubated at 40 ° C for 0, 10, 20 and 30 minutes. Then 0.1 ml of the reaction medium is added to 0.6 ml of a 1M sodium carbonate solution. The optical density is read at 400 nm. The slope of the line obtained as a function of the duration of the incubation makes it possible to estimate the alpha-galactosidasic activity.
L'enzyme utilisé possède une activité correspondant à la dégradation de 52 mg de raffinose par mg d'enzyme en 2 heures à 40°C et pH 6,5.  The enzyme used has an activity corresponding to the degradation of 52 mg of raffinose per mg of enzyme in 2 hours at 40 ° C and pH 6.5.
Les teneurs en raffinose ont été déterminées sur les aliments BR et BRE. Afin de tenir compte des transformations susceptibles d'intervenir à 25°C durant la période de mesure, les aliments ont été conservés pendant 3 jours à cette température avant analyse.  The raffinose contents were determined on BR and BRE foods. In order to take into account the changes likely to occur at 25 ° C during the measurement period, the food was kept for 3 days at this temperature before analysis.
Le raffinose a été extrait avec un mélange éthanol/eau (80/20) à ébullition et à reflux; l'emploi d'éthanol permet d' inactiver rapidement toute activité alpha-galactosidasique. Après extraction, le raffinose a été dosé par chroma togreph ie liquide à haute pression selon la méthode de QUEMENER (1988 - Improvement in the high pressure liquid chromatographic détermination of amino-sugars and alpha-gaiactosides in Faba bean, lupine and pea. J. Agric. Food. Chem -36: 754 - 759).  The raffinose was extracted with an ethanol / water mixture (80/20) at boiling point and at reflux; the use of ethanol makes it possible to rapidly inactivate any alpha-galactosidasic activity. After extraction, the raffinose was determined by chroma togreph ie high pressure liquid according to the QUEMENER method (1988 - Improvement in the high pressure liquid chromatographic determination of amino-sugars and alpha-gaiactosides in Faba bean, lupine and pea. J. Agric. Food. Chem -36: 754 - 759).
La teneur en raffinose a été dosée dans les aliments BR et BRE afin de déterminer le taux d'hydrolyse sous l'action éventuelle de l'alpha-galactosidase. La teneur des deux aliments en raffinose est identique et égale à 5,15% de matière sèche (MS): l'enzyme n'hydrolyse pas le raffinose dans l'aliment et les animaux ont reçu des quantités identiques de raffinose.  The raffinose content was measured in BR and BRE foods in order to determine the rate of hydrolysis under the possible action of alpha-galactosidase. The raffinose content of the two foods is identical and equal to 5.15% of dry matter (DM): the enzyme does not hydrolyze raffinose in the food and the animals received identical amounts of raffinose.
Durant le déroulement de l'expérimentation, les aliments ont été conservés au froid, à 4°C.
Figure imgf000010_0001
Figure imgf000011_0001
During the course of the experiment, the food was kept cold at 4 ° C.
Figure imgf000010_0001
Figure imgf000011_0001
b) - Cycles d'alimentation des rats  b) - Rat feeding cycles
L'expérimentation a été réalisée sur 4 rats mâles de race WISTAR recevant successivement, dans un ordre aléatoire, selon un dispositif en carré latin (tableau 4), quatre régimes (PI, PII, PIII, PIV) différant par leur teneur en alpha-galactosides et en alpha-galactosidase. Les animaux étaient âgés de 8 semaines en début d'expérimentation et 15 semaines en fin d'expérimentation. The experiment was carried out on 4 male rats of the WISTAR breed receiving successively, in a random order, according to a Latin square device (Table 4), four regimes (PI, PII, PIII, PIV) differing in their alpha- galactosides and alpha-galactosidase. The animals were 8 weeks old at the start of the experiment and 15 weeks old at the end of the experiment.
Figure imgf000012_0001
Figure imgf000012_0001
Pour chaque animal, l'expérimentation comporte donc 4 périodes correspondant à chacun des 4 régimes. Chaque période comprend une période d'adaptation de 9 jours, effectuée dans des cages individuelles de croissance et une période de mesure de 3 jours.  For each animal, the experiment therefore includes 4 periods corresponding to each of the 4 diets. Each period includes an adaptation period of 9 days, carried out in individual growth cages and a measurement period of 3 days.
c) - Consommation alimentaire des animaux  c) - Food consumption of animals
Durant les périodes d'adaptation, les animaux ont été nourris ad libitum; la distribution d'aliment a été effectuée quotidiennement. Les refus ont été collectés quotidiennement et regroupés sur la durée de la période. Les teneurs en MS des aliments et des refus ont été déterminées par séchage à poids constant à 100°C.  During the adaptation periods, the animals were fed ad libitum; food was distributed daily. Refusals were collected daily and grouped over the duration of the period. The DM contents of the food and the rejects were determined by drying at constant weight at 100 ° C.
Lors des périodes de mesure, les aliments ont été distribués en une fois à raison de 110% de la consommation de 3 jours mesurée lors de la période d'adaptation. Les refus ont été collectés en fin de période de mesure. Les teneurs en MS des aliments et des refus ont été déterminées.  During the measurement periods, the food was distributed at once at the rate of 110% of the 3-day consumption measured during the adaptation period. Refusals were collected at the end of the measurement period. The DM content of the food and the refusals have been determined.
Le comportement général des animaux a été très satisfaisant. La consommation alimentaire, représentée tableau 5, est voisine pour tous les régimes expérimentaux et proche de 20 g de MS/j/animal. Les régimes ont été bien acceptés, sans effet néfaste de la présence de raffinose ou de la préparation enzymatique. En particulier, aucun cas de diarrhée n'a été constaté. La croissance des animaux (Figure 1) a été mesurée à titre indicatif. Non différente statistiquement selon les régimes, elle se situe en moyenne à 4,8 g/j/animal. The general behavior of the animals was very satisfactory. Food consumption, shown in Table 5, is close to all experimental diets and close to 20 g DM / d / animal. The diets were well accepted, with no detrimental effect from the presence of raffinose or the enzyme preparation. In particular, no case of diarrhea was noted. The growth of the animals (Figure 1) was measured for information. Not statistically different depending on the diet, it is on average 4.8 g / d / animal.
La Figure 1 est un graphique illustrant l'influence de la nature des régimes sur la croissance des animaux. On a porté en ordonnées, exprimés en grammes calculés sur trois jours, les chiffres correspondant à la croissance des rats.  Figure 1 is a graph illustrating the influence of the nature of the diets on animal growth. The figures corresponding to the growth of the rats were plotted on the ordinate, expressed in grams calculated over three days.
L'indice de consommation est en moyenne de 4,4. Cette valeur élevée traduit essentiellement une croissance faible des animaux; les conditions de contention imposées par la présence en chambre respiratoire peuvent expliquer ce résultat.  The consumption index averages 4.4. This high value essentially reflects a low growth of the animals; the conditions of restraint imposed by the presence in the respiratory chamber may explain this result.
Figure imgf000013_0001
Figure imgf000013_0001
d) - Détermination des productions de gaz intestinaux  d) - Determination of intestinal gas production
La mesure de la production de gaz intestinaux consécutive aux régimes expérimentaux a été réalisée au moyen d'une chambre respiratoire dont le schéma de principe est représenté Figure 1. L'animal en expérience est placé dans une enceinte (1) où il a à sa disposition de l'eau à volonté et l'aliment testé. Le renouvellement et l'homogénéisation de l'air sont assurés par une pompe à membrane (2). Le gaz carbonique (CO2) dégagé est capté par bar bottage dans une solution aqueuse de potasse (3). L'eau provenant de la respiration est fixée par passage sur gel de silice ACTIGEL (4). Une électrode à oxygène (5), placée en sortie de cage, mesure la concentration du circuit en oxygène et permet de la maintenir constante par action sur un régulateur (6) relié à une électrovanne (7), elle même reliée è une bouteille d'oxygène (8). Le sens de circulation des gaz dans le dispositif est signifié par la flèche (F). The measurement of intestinal gas production following the experimental regimes was carried out by means of a respiratory chamber, the diagram of which is shown in Figure 1. The experimental animal is placed in an enclosure (1) where it has at its water at will and the food tested. Air renewal and homogenization are ensured by a diaphragm pump (2). Carbon dioxide (CO 2 ) released is captured by bar kicking in an aqueous solution of potash (3). The water from respiration is fixed by passage over ACTIGEL silica gel (4). An oxygen electrode (5), placed at the outlet of the cage, measures the concentration of the oxygen circuit and makes it possible to keep it constant by action on a regulator (6) connected to a solenoid valve (7), itself connected to a cylinder of oxygen (8). The direction of gas flow in the device is indicated by the arrow (F).
Durant les périodes de mesure, la température a été maintenue à 25°C; l'hygrométrie, suivie en continu, a été comprise entre 50 et 60%.  During the measurement periods, the temperature was maintained at 25 ° C; the humidity, continuously monitored, was between 50 and 60%.
Au cours des périodes de mesures, deux échantillons quotidiens d'air ont été prélevés dans la chambre respiratoire pour analyse de l'hydrogène et du méthane.  During the measurement periods, two daily air samples were taken from the breathing chamber for analysis of hydrogen and methane.
Les déterminations des concentrations en hydrogène et en méthane ont été effectuées dans les conditions suivantes:  The hydrogen and methane concentrations were determined under the following conditions:
* chromatographie en phase gazeuse (QUINTRON) * gas chromatography (QUINTRON)
* colonne remplie (2m, température ambiante) * phase: tamis moléculaire * column filled (2m, room temperature) * phase: molecular sieve
* gaz vecteur: air médical.  * carrier gas: medical air.
La pente de la régression de la concentration de gaz en fonction du temps a été utilisée pour déterminer la concentration théorique de chacun des gaz issus des fermentations intestinales au bout de 3 jours.  The slope of the regression of the gas concentration as a function of time was used to determine the theoretical concentration of each of the gases from intestinal fermentations after 3 days.
La production d'hydrogène étant seule reconnue comme liée à la fermentation de sucres indigestibles, les résultats relatifs à la production de méthane n'ont pas été pris en compte.  Since the production of hydrogen is the only one recognized as linked to the fermentation of indigestible sugars, the results relating to the production of methane have not been taken into account.
Les concentrations en hydrogène pour les différents régimes sont représentées dans le tableau 6. Le régime BR donne des valeurs très élevées et significativement différentes des autres régimes (p<0,05). La présence d'alpha-galactosidase conduit à une disparition quasi totale des fermentations, abaissées au niveau du régime de base. Les régimes B et BE donnent des résultas très semblables: la préparation enzymatique ajoutée au régime n'a aucune action sur la fraction pariétale de l'aliment. Sa seule action décelable consiste donc en une dégradation du raffinose contenu dans les régimes expérimentaux. The hydrogen concentrations for the different regimes are shown in Table 6. The BR regime gives very high values and significantly different from the other regimes (p <0.05). The presence of alpha-galactosidase leads to an almost total disappearance of the fermentations, lowered to the level of the basic regime. The B and BE diets give very similar results: the enzyme preparation added to the diet has no effect on the parietal fraction of the food. Its only detectable action therefore consists in a degradation of the raffinose contained in the experimental regimes.
Figure imgf000015_0001
Figure imgf000015_0001
Le résultat majeur de cette expérimentation est la mise en évidence d'une diminution des fermentations liées à l' ingestion de raffinose consécutive à l'incorporation d'une activité alpha-galactosidasique dans l'aliment. L'absence de fermentation traduit une hydrolyse totale du raffinose qui ne parvient plus au côlon. Le raffinose n'est pas hydrolyse dans l'aliment où il a été retrouvé intact: l'action de l'enzyme s'est située dans le tube digestif. Il est également montré dans cette expérience que le niveau d' incorporation de l'enzyme et ses conditions d'action, proches de celles existant dans l' intestin grêle, ont conduit à une hydrolyse totale du raffinose ajouté. Les conditions d'action de l'enzyme, proches de celles existant dans l'intestin grêle et le niveau d'incorporation de l'enzyme au régime sont des paramètres favorables. Cette expérimentation démontre l'activité dans le tube digestif d'un enzyme incorporé dans l'aliment. The major result of this experiment is the demonstration of a reduction in the fermentations linked to the ingestion of raffinose following the incorporation of an alpha-galactosidasic activity in the food. The absence of fermentation translates to a total hydrolysis of raffinose which no longer reaches the colon. Raffinose is not hydrolyzed in the food where it was found intact: the action of the enzyme is located in the digestive tract. It is also shown in this experiment that the level of incorporation of the enzyme and its conditions of action, close to those existing in the small intestine, led to a total hydrolysis of the added raffinose. The conditions of action of the enzyme, close to those existing in the small intestine and the level of incorporation of the enzyme into the diet are favorable parameters. This experiment demonstrates the activity in the digestive tract of an enzyme incorporated into the food.
L'expérimentation réalisée montre aussi que l'alpha-galac tos idase étudiée résiste à la dégradation par des enzymes endogènes et exprime sa potentialité dans le tube digestif, permettant ainsi, ajoutée à un régime alimentaire d'en détruire totalement les alpha-galactosides.  The experience also shows that the alpha-galac tos idase studied resists degradation by endogenous enzymes and expresses its potential in the digestive tract, thus allowing, added to a diet to completely destroy the alpha-galactosides.

Claims

REVENDICATIONS
1. Composition comprenant au moins un produit pour l'alimentation humaine ou animale, ledit produit contenant au moins un constituant échappant à la dégradation lors de la digestion non microbienne par l'organisme, ladite composition étant caractérisée en ce qu'elle comprend en outre au moins un enzyme capable d'hydrolyser ledit constituant au cours de la digestion, ledit enzyme n'étant pas présent naturellement dans le système digestif et étant sensiblement sans effet sur ledit constituant avant l' ingestion de la composition.  1. Composition comprising at least one product for human or animal food, said product containing at least one constituent escaping degradation during non-microbial digestion by the organism, said composition being characterized in that it also comprises at least one enzyme capable of hydrolyzing said constituent during digestion, said enzyme not being present naturally in the digestive system and being substantially without effect on said constituent before ingestion of the composition.
2. Composition selon la revendication 1, caractérisée en ce qu'elle est présentée sous forme sèche.  2. Composition according to claim 1, characterized in that it is presented in dry form.
3. Composition selon la revendication 2, caractérisée en ce qu'elle est présentée sous forme de farine ou sous forme agglomérée, tels que des granules, ou autres formes de présentation usuelle existant pour l'alimentation humaine ou animale.  3. Composition according to claim 2, characterized in that it is presented in the form of flour or in agglomerated form, such as granules, or other forms of usual presentation existing for human or animal food.
4. Composition selon l'une quelconque des revendications 1 à 3, caractérisée en ce que le produit convenant à l'alimentation est choisi parmi les grains, graines, tourteaux, et autres sous-produits industriels.  4. Composition according to any one of claims 1 to 3, characterized in that the product suitable for food is chosen from grains, seeds, oil cakes, and other industrial by-products.
5. Composition selon l'une quelconque des revendications 1 à 4, caractérisée en ce que l'enzyme est spécifique du ou des constituants à hydrolyser dans ledit produit pour l'alimentation humaine ou animale.  5. Composition according to any one of claims 1 to 4, characterized in that the enzyme is specific to the constituent (s) to be hydrolyzed in said product for human or animal food.
6. Composition selon l'une quelconque des revendications 1 à 5, caractérisée en ce que ledit enzyme est présent dans un mélange d'enzymes ayant des activités diverses.  6. Composition according to any one of claims 1 to 5, characterized in that said enzyme is present in a mixture of enzymes having various activities.
7. Composition selon l'une quelconque des revendications 1 à 6, caractérisée en ce que ledit enzyme est présent en une quantité efficace pour hydrolyser au moins partiellement ledit constituant au cours de la digestion.  7. Composition according to any one of claims 1 to 6, characterized in that said enzyme is present in an amount effective to at least partially hydrolyze said constituent during digestion.
8. Composition selon l'une quelconque des revendi cations 1 à 7, caractérisée en ce que ledit enzyme est choisi parmi les enzymes spécifiques dans les conditions notamment de pH et de température de la digestion dans l'organisme. 8. Composition according to any one of the claims cations 1 to 7, characterized in that said enzyme is chosen from specific enzymes under the conditions in particular of pH and temperature of digestion in the organism.
9. Composition selon l'une quelconque des revendications 1 à 8, caractérisée en ce que le constituant résistant à la dégradation est un alpha-galactoside et en ce que ledit enzyme est une alpha-galactosidase.  9. Composition according to any one of claims 1 to 8, characterized in that the component resistant to degradation is an alpha-galactoside and in that said enzyme is an alpha-galactosidase.
10. Composition selon l'une quelconque des revendications 1 à 9, caractérisée en ce que ledit enzyme est thermorésistant notamment en vue de résister aux températures mises en jeu lors de la préparation de la composition.  10. Composition according to any one of claims 1 to 9, characterized in that said enzyme is heat-resistant in particular in order to resist the temperatures involved in the preparation of the composition.
11 . Procédé pour l a va l o r i sa t i on d ' un p r o du i t pour l'alimentation humaine ou animale, contenant au moins un constituant échappant à la digestion non-microbienne dans l'organisme, ledit procédé étant caractérisé en ce qu'on mélange intimement audit produit une quantité efficace d'au moins un enzyme capable d'hydrolyser ledit constituant au cours de la digestion avant la fin de l'intestin grêle, ledit enzyme n'étant pas présent naturellement dans le système digestif et étant sensiblement sans effet sur ledit constituant avant l'ingestion de la composition.  11. Process for the va lori sa ti on of a pro du it for human or animal food, containing at least one constituent escaping non-microbial digestion in the organism, said process being characterized in that it is intimately mixed said product produces an effective amount of at least one enzyme capable of hydrolyzing said constituent during digestion before the end of the small intestine, said enzyme not being present naturally in the digestive system and being substantially without effect on said constituent before ingestion of the composition.
PCT/FR1990/000374 1989-05-30 1990-05-29 Nutritional composition containing an enzyme WO1990014773A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907117A FR2647638A1 (en) 1989-05-30 1989-05-30 FOOD COMPOSITION CONTAINING AN ENZYME
FR89/07117 1989-05-30

Publications (1)

Publication Number Publication Date
WO1990014773A1 true WO1990014773A1 (en) 1990-12-13

Family

ID=9382175

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1990/000374 WO1990014773A1 (en) 1989-05-30 1990-05-29 Nutritional composition containing an enzyme

Country Status (2)

Country Link
FR (1) FR2647638A1 (en)
WO (1) WO1990014773A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344196B1 (en) 1989-05-16 2002-02-05 Block Drug Company, Inc. Compositions and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833465A1 (en) * 2001-12-18 2003-06-20 Medhat Chahbandar High-energy livestock feed consists of leaves of Cynara Scolymus combined with de-oiled cake made from the seeds of the same plant

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846239A (en) * 1972-07-24 1974-11-05 Monsanto Co Process for the preparation of heat-resistant alpha-galactosidase enzyme
EP0280226A2 (en) * 1987-02-23 1988-08-31 Suomen Sokeri Oy Poultry feed, feeding method, and procedure for improving the digestibility of poultry feed
EP0285098A2 (en) * 1987-03-30 1988-10-05 Suomen Sokeri Oy Feed raw material and feed containing zero fibre and procedure for producing these

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846239A (en) * 1972-07-24 1974-11-05 Monsanto Co Process for the preparation of heat-resistant alpha-galactosidase enzyme
EP0280226A2 (en) * 1987-02-23 1988-08-31 Suomen Sokeri Oy Poultry feed, feeding method, and procedure for improving the digestibility of poultry feed
EP0285098A2 (en) * 1987-03-30 1988-10-05 Suomen Sokeri Oy Feed raw material and feed containing zero fibre and procedure for producing these

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 106, No. 9, Mars 1987, (Columbus, Ohio, US); H. GRAHAM et al.: "Influence of Beta-Glucanase Supplementation on Digestion of a Barley-Based Diet in the Pig Gastrointestinal Tract", voir page 522* Resume 66244w, & Nutr. Rep. Int. 1986, 34(6), 1089-96* *
Poultry Science, Vol. 65, No. 1, 1986, (Champaign, US), M.J. EDNEY et al.: "Application of a Simple Radial Gel Diffusion Assay for Endo-Beta-Glucanase Activity in Dietary Enzyme Supplements", pages 72-77 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344196B1 (en) 1989-05-16 2002-02-05 Block Drug Company, Inc. Compositions and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars

Also Published As

Publication number Publication date
FR2647638A1 (en) 1990-12-07

Similar Documents

Publication Publication Date Title
JP4894015B2 (en) Method for producing explosive fermented bagasse
EP2714918A1 (en) Extraction of chitins in a single step by enzymatic hydrolysis in an acid medium
FR2688793A1 (en) COMPOSITION OF HYPOCARIOGENIC SACCHARIDES SACCHARIDES, PROCESS FOR PREPARING THE SAME AND APPLICATION THEREOF.
Rages et al. Alkaline hydrolysis of olive fruits wastes for the production of single cell protein by Candida lipolytica
WO2019180388A1 (en) Veterinary composition comprising superoxide dismutase and at least one hydrolysate of proteins rich in bioassimilable peptides
FR2690445A1 (en) Alginate oligosaccharide and its manufacturing process.
Sáez et al. Evaluation of Nannochloropsis gaditana raw and hydrolysed biomass at low inclusion level as dietary functional additive for gilthead seabream (Sparus aurata) juveniles
EP3558027B1 (en) Product for improving the use of fibre in feed
WO2010015708A1 (en) Feed for milk-producing animals, method for the production thereof, use thereof and milk produced
CA3179259A1 (en) Method for producing larvae rearing substrate
WO1990014773A1 (en) Nutritional composition containing an enzyme
FR2942939A1 (en) PROBIOTIC YEAST STABLE FOR GRANULATION, PROBIOTIC COMPOSITIONS COMPRISING THE SAME, PROCESS FOR THEIR PREPARATION AND USES THEREOF
JP2004524850A (en) Palm kernel meal with mannose
EP2348882B1 (en) Use of natural substances as feed additives for animals of the genus equidae
CA2334424A1 (en) Nitrogenous composition resulting from the hydrolysis of corn gluten, and its production process
FR2670090A1 (en) PROCESS FOR THE PREPARATION OF PROTEIN BASES FOR THE MANUFACTURE OF AROMAS.
EP1983844B1 (en) Method for production of active extracts from soya beans and corresponding uses of the produced extracts
CA3162354A1 (en) Fermented pea solubles
JP7086437B1 (en) Manufacturing method of processed ginger product and processed ginger product
KR102613838B1 (en) Production method of salted seafood seasoning extracts using low temperature, salt and enzymatic hydrolysis
TWI460273B (en) Enzymatic synthesis process of oligosaccharide esters
WO2023148460A1 (en) Protein having a xylanase activity
JP3764496B2 (en) Alcoholic liver dysfunction inhibitor
JPH09132533A (en) Suppressant for both ulcer and hepatopathy comprising lactic acid bacterium fermentation product
WO2024003266A1 (en) Microcapsules comprising a uv filter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE